Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
WuXi AppTec (603259 CH)
Watchlist
442
Analysis
Health Care
•
China
WuXi AppTec Co., Ltd. manufactures medical products. The Company produces biological agents, antibodies, biological diagnostic reagents, and other products. WuXi AppTec also provides biological analysis, technical study, and other services.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Cross Asset Strategy
•
17 Jun 2026 14:01
•
Syndicated
CX Daily: As Retired Battery Wave Approaches, China Moves to Clean Up Recycling
TOP STORIES In Depth: As Retired Battery Wave Approaches, China Moves to Clean Up Recycling China is bracing for a wave of batteries coming to...
Caixin Global
Follow
98 Views
Share
bullish
•
Cross Asset Strategy
•
27 Dec 2024 13:50
•
Syndicated
CX Daily: China Launches New Plan to Tackle Tuberculosis
Tuberculosis / In Depth: China launches new plan to tackle tuberculosis In Nanshan district in the southern metropolis of Shenzhen, one of the...
Caixin Global
Follow
489 Views
Share
bullish
•
Thematic (Sector/Industry)
•
15 Sep 2022 01:04
•
Broker
The U.S. Executive Order on Its Biotech Industry May Not Materiality Affect Chinese CRO Industry
The U.S. launched new support to its biotech production, aiming to boost biomanufacturing in pharmaceuticals but also in other industries such as...
Quam Securities
Follow
346 Views
Share
bullish
•
Cross Asset Strategy
•
22 Jul 2022 10:54
•
Syndicated
CX Daily: How Saving Poyang Lake Will Alter A Complex Ecosystem
In Depth: How saving Poyang Lake will alter a complex ecosystem. Huawei steps up debt financing with $593 million onshore bond sale
Caixin Global
Follow
446 Views
Share
bullish
•
WuXi AppTec
•
01 Nov 2023 18:52
•
Broker
WuXi AppTec (603259 CH) – Peptide Business Becoming a New Growth Driver
WuXi AppTec reported 3Q23 revenue of RMB10,670mn, up 0.3% YoY, and attributable recurring net income of RMB2,948mn, up 23.8% YoY
CMB International
Follow
331 Views
Share
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4
x